fbpx Yourgene Health plc - Home

 

Videos

Investor Meet Company - Annual Results for the year ended 31 March 2021 YGEN Annual Results Aug 2021 FINAL Page 01
Yourgene Health plc - Full Results 2021 YGEN Annual Results Aug 2021 FINAL Page 01
Business Update April 2021 2021 Apr 28 Trading Update Page 1
Trading update - Feb 2021 trading update feb 2021
Interim Results 2020 half year 2020
Launch of Yourgene Genomic Services yourgene genomic services logo 1

Company update with Chief Executive Officer, Lyn Rees

company update 18th august
Yourgene Health
Acquisition of Coastal Genomics Inc., 
Investor Presentation
coastal presentation
Yourgene Health plc - Full Results 2020 YGEN Results image Page 01
Company update with Chief Executive Officer, Lyn Rees lyn film
Interim Results 2019 interim results 2019
Q&A with Lyn Rees, CEO Screenshot 2019 11 08 at 152725  

Capital Markets Day 2019

 

Capital Markets Day 2019
   

Lyn Rees, Proactive London Interview 2019

Yourgene Health PLC (LON:NIPT) chief executive Lyn Rees tells Proactive London's Andrew Scott they've been making excellent commercial progress with their flagship NIPT product.

In 2018 the firm entered into a legal settlement and licence agreement with Illumina, ending all patent litigation around the test.

"It feels as if we've pressed the reset button ... we knew we had this great technology, we knew the pregnant mums really loved this technology because it's faster and more effective, but because of the litigation it made it difficult to sell", Rees says.

"Now, we've got no litigation worries so we've got the whole world to look at from an addressable market perspective and the fact we're already in 20 countries, that gives us a good springboard to go into probably another 30 countries over the next three years".

Lyn Rees - Yourgene Health PLC. Proacative London Interview